Investorideas.com - LKP Signs Definitive Business Combination Agreement for RTO with Osoyoos Cannabis Inc.
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Tuesday, July 17, 2018
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSX: $APH.TO, TSX: $TGOD.TO, CSE: $MTEC.C, CSE: $CHV.C, CSE: $CROP.C
Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move: TSX: $APH.TO,
TSX: $TGOD.TO, CSE: $MTEC.C, CSE: $CHV.C, CSE: $CROP.C
July 17th Potcast
sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis
company with a new disruptive drug delivery platform: DehydraTECH
Pt. Roberts, WA; Delta, BC –July 17, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/07172Potcasts-TSX-APH-TGOD-CSE-MTEC-CHV-CROP.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today’s podcast features announcements
from Aphria Inc.
trading on the TSX as APH and US OTC as APHQF, The Green Organic
Dutchman Holdings Ltd. trading on the TSX as TGOD, Cannvas MedTech Inc. trading on the CSE as MTEC, Canada House
Wellness Group Inc. trading on the CSE as CHV and CROP Infrastructure Corp. trading on the CSE as CROP and the OTC
as CRXPF.
But first,
with Canada’s legalization fast approaching, a new poll from YouGov Omnibus finds that nearly two in five Americans
(38%) say that the new law will have a positive effect on Canada’s future. Less
than a quarter (24%) say that legalization will negatively affect the nation
and a fifth (20%) say it will have no effect.
Positive perception of Canada’s legalization of marijuana is highest among those who live in the West (41%). This comes as little surprise, given that six states in this region have legalized both recreational and medical marijuana.
By party affiliation, nearly one in two Republicans (49%) believe that legalization will have a negative impact on Canada’s future. One in three independents (36%) and one in two Democrats (50%) hold that the matter will have a positive effect, the leading response for both parties.
Optimism for Canada’s new legislation appears to increase with income level. Starting with those who earn less than $40,000 a year, 36% have a positive perception of the law. That figure increases to 38% when those who earn $40,000 to $80,000 are asked and culminates at 41% when those who earn over $80,000 are examined.
Positive perception of Canada’s legalization of marijuana is highest among those who live in the West (41%). This comes as little surprise, given that six states in this region have legalized both recreational and medical marijuana.
By party affiliation, nearly one in two Republicans (49%) believe that legalization will have a negative impact on Canada’s future. One in three independents (36%) and one in two Democrats (50%) hold that the matter will have a positive effect, the leading response for both parties.
Optimism for Canada’s new legislation appears to increase with income level. Starting with those who earn less than $40,000 a year, 36% have a positive perception of the law. That figure increases to 38% when those who earn $40,000 to $80,000 are asked and culminates at 41% when those who earn over $80,000 are examined.
Aphria Inc.
announced that the Company's planned expansion into Latin America and the
Caribbean with the proposed acquisition of industry-leading companies in
Colombia, Argentina, Jamaica and a right of first offer and refusal in respect
of Brazil through a definitive share purchase agreement with Scythian
Biosciences Inc. Aphria will acquire 100% of the issued and outstanding common
shares of LATAM Holdings Inc., a direct, wholly-owned subsidiary of Scythian.
Highlights of the Transaction include:
·
Solidifies
Aphria's leadership position in the global cannabis industry
·
Provides
Aphria with world class assets in the most advanced regulatory jurisdictions
across LATAM and Caribbean markets, from which it can further grow and expand
its international operations
·
Strengthens
Aphria's leading international management team with the addition of proven
local LATAM and Caribbean executives
·
Establishes
Aphria's presence in the most advanced strategic market in South America,
Colombia
·
Gains first
mover advantage in Argentina for eventual in country cultivation
·
Acquires
market leadership in Jamaica with the only producing Tier 3 cultivator license
in the country
·
Yields
strategic rights to potentially expand into Brazil, the largest population in
South America
·
Delivers
accretive cash flow beginning in calendar 2019
The Green
Organic Dutchman Holdings Ltd. announced, in conjunction with Epican Medicinals
(“Epican”), the successful opening of its first legal cannabis retail store in
Jamaica, on Saturday, July 14th. This flagship location provides Epican and
TGOD with immediate revenue from the sale of premium Jamaican grown organic cannabis
and further exemplifies TGOD’s value-added approach to partnerships.
The ~4,000
sq. ft. flagship dispensary in Kingston represents the first of several Epican
Herb Houses scheduled to be completed across Jamaica by the end of 2018. These
locations will serve the medical needs of Jamaica’s 3 million residents and
over 3.5 million visitors each year.
Cannvas MedTech Inc., a leading
business technology company within the cannabis space, announced the
appointment of Radu Puscasu as Data Protection Officer. With over 14 years of
experience, Radu has been heavily involved in creating meaningful customer
relationship experiences through secure technology. He has held senior roles at
Bell Media, TD Bank Securities (Equity Derivative Solutions and Data Management
Services), and Pitney Bowes and has worked with client companies such as
Takeda, AstraZenaca, Pfizer, and Novartis.
Cannvas also
announced its intention to expand into Germany, one of the fastest growing
medical cannabis marketplaces in the world. The country has fully embraced
medical cannabis as a legitimate, doctor-prescribed, insurance-paid, and
pharmacy-provided medical and healthcare product.
Canada House
Wellness Group Inc. announced that it has entered into, through its wholly
owned subsidiary Abba Medix Corp., an exclusive licensing agreement with
Medicine Man Technologies Inc. (OTCQB:MDCL), one of the United States' leading
cannabis branding and consulting companies, for deployment of its intellectual
property and product lines (Three a Light ®, Success Nutrients ®, General
Intellectual Property) into the Canadian marketplace.
The
licensing agreement calls for payment of $4.65M (CAD) in the form of cash and
stock for licensing of Medicine Man’s intellectual property, product lines, and
assignment of an existing Cultivation MAX agreement to Canada House.
CROP Infrastructure Corp. announced
today that it has completed the retrofit and upgrades at its ‘The Park’
state-of-the-art facility in Washington State. Crop’s licensed tenant
grower there has now advised that it expects to harvest an initial 350 pounds
of high quality cannabis within six weeks and will be at full scale production
in September 2018.
The Park
cannabis greenhouse is 35,000 sqft and sits on approximately nine acres of land.
The facility recently underwent a complete retro-fit for hydroponic automation
and the addition of 500 Gavita HPS grow lights. The greenhouse facility has
five flowering bays that are designed to yield, at full scale production,
approximately 12,000 pounds of high quality cannabis annually (~1,000 pounds
per month). The facility requires no additional capex for upgrades in order
that the tenant may reach full commercial production.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment.
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com cannabis/marijuana and hemp
content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and
stock directory pages, a cannabis investor group on Linkedin.com , the 420
Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp Stocks? Check out our stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana
/ Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
Monday, July 16, 2018
Investorideas.com - #Cannabisstocks: Hydropothecary (TSX:HEXO) 'gets intimate' with release of Fleur de Lune, its first medical cannabis oil for personal use
Investorideas.com - #Cannabisstocks: Hydropothecary (TSX:HEXO) 'gets intimate' with release of Fleur de Lune, its first medical cannabis oil for personal use
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - #Cannabisstocks: Tidal Royalty Corp. (CSE: RLTY.U) (OTC: TDRYF) Announces Listing on United States OTC Market
Investorideas.com - #Cannabisstocks: Tidal Royalty Corp. (CSE: RLTY.U) (OTC: TDRYF) Announces Listing on United States OTC Market
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - Chef Ricky Flickenger Debuts Cannabis Cookbook 'Cannabis & the Art of Infusion'
Investorideas.com - Chef Ricky Flickenger Debuts Cannabis Cookbook 'Cannabis & the Art of Infusion'
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Subscribe to:
Posts (Atom)